Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.44% to 10697.57, DAX (0.50%) to 25440.81, CAC40 (0.76%) to 8117.78, STOXX 600 (0.49%) to 635.99

Sep 14 ,2026

  • Synopsis:

    • European equity markets closed mostly lower Monday. German DAX, French CAC and Spanish IBEX were under pressure but FTSE 100 and Swiss SMI gained. Follows the second consecutive week of lower levels. Health care, media and food&beverage were the best performing sectors. Basic resources, construction and utilities lagged.

    • Lot of moving parts for investors to digest. AI trade under pressure after Anthropic CEO Amodei called for slowing development of AI models amid safety concerns. OpenAI CEO Altman also rules out IPO this year due to 'unacceptable' safety risks. Oil also sharply higher following weekend Middle East developments. Lot of focus on Houthi capture of strategic locations along Yemen's southern coast, giving it leverage over Bab el-Mandeb Strait in risk to shipping. Saudi Arabia shut East-West pipeline due to damage from drone strike. Planned meeting between Iran and Gulf foreign ministers on Monday to discuss Strait of Hormuz management postponed amid lack of consensus.

    • European markets have experienced heightened sensitivity to energy dynamics due to dependency on energy imports. Recall that last week's energy price gains were the catalyst for a steepening in rate hike expectations. Interest rate swaps market showing ECB and BoE potentially hiking rates up to four times over the next year. Note, however, that the BoE is widely expected to leave rates on hold this week. Elsewhere, speculation that Eurozone governments negotiating package for three top ECB roles to be agreed by year-end, with President Lagarde set to announce early departure.

    • Quiet macro data calendar with final Swedish CPI unchanged from flash, while Swiss producer prices accelerated in August. Meanwhile, ECB executive board member Schnabel said recent energy price developments are quite concerning.

    • In M&A news, Uniper (UN0.GR) sold its 20% stake in OPAL gas pipeline to Hy24. On the rumours mill, the FT reported that Recordati (REC.IM) holders are unhappy with CVC's (CVC.NA) take-private bid and also that Euronext (ENX.FP) is willing to merge with Deutche Börse (DB1.GR). Telefónica (TEF.SM) reportedly is once again eyeing control of Zegona's (ZEG.LN) Spanish operations.

    • On a light reporting front, ISS (ISS.DC) issued new mid-term financial targets and GlobalData (DATA.LN) posted earnings and also lowered its FY guidance.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Health Care +2.74%, Media +2.44%, Food & Beverage +2.22%, Persnl & HHold Goods +1.43%, Insurance +0.70%, Chemicals +0.43%, Travel & Leisure (0.37%), Telecom (0.47%)

      • Underperformers:

        • Basic Resources (2.52%), Construct & Mtls (2.38%), Utilities (2.16%), Technology (2.12%), Ind Goods & Svcs (1.95%), Banks (1.08%), Oil & Gas (0.76%), Autos & Parts (0.74%), Real Estate (0.61%), Retail (0.55%), Financial Svcs (0.55%)

    • Macro:

      • ECB:

        • Eurozone governments want to agree package over top ECB roles by year-end - FT, Politico, Bloomberg

      • EU:

        • EU chief rejects banks' bid to split reform package in two - Bloomberg

        • Canada seeks EU associate member status as US trade talks collapse - euronews

      • France:

        • Poll shows French extreme candidates steam ahead in 2027 presidential race - Reuters

      • Germany:

        • CDU projected to become strongest party Lower Saxony's local elections, but AfD triples vote - Handlelsblatt

      • Ireland:

        • 'Westminster's time is coming to an end', say SF, SNP and Plaid Cymru leaders - RTE

        • President Trump announces removal of tariff on whisky made in Republic, no change for rest of EU - RTE

      • Italy:

        • Meloni sees Italy 2026 growth at 1%, matching Eurozone - Reuters

      • Sweden:

        • Left edges ahead in Swedish election thriller - politico

        • Election authority projects Sweden's centre-left opposition bloc to win election by one seat - Guardian

      • UK:

        • PM Burnham to meet business leaders to discuss growth - Reuters

        • Faces £258B infrastructure spending gap - FT

        • Scottish, Welsh and Northern Irish leaders meet to plan break-up of United Kingdom - Telegraph

      • Sovereign credit rating reviews after the close Fri included:

        • Italy BBB+ affirmed, outlook stable - Fitch

        • Slovenia A+ affirmed, outlook stable - Fitch

        • ESFS AA+ reaffirmed, outlook stable - Scope

        • ESM AAA reaffirmed, outlook stable - Scope

        • Netherlands AAA reaffirmed, outlook stable - Scope

        • Spain A+ reaffirmed, outlook to stable from positive - Scope

        • UK AA reaffirmed, outlook stable - Scope

        • S&P performed annual reviews of the credit ratings of Croatia, Serbia and Spain

    • Company news:

      • Notable Gainers

        • +21.2% TRB.LN (Tribal Group £0.81, +0.14) -- proposed acquisition by Main Capital Partners for c. £189.3M

        • +9.1% PANR.LN (Pantheon Resources £0.12, +0.01) -- H1 earnings

        • +8.2% MPE.LN (M.P. Evans Group £20.40, +1.54) -- H1 earnings

        • +8.0% KEYS.LN (Keystone Law Group £6.65, +0.49) -- H1 earnings

        • +6.6% CAP.FP (Capgemini €110.15, +6.80) -- to sell Capgemini Government Solutions

        • +5.3% CPR.IM (Davide Campari-Milano €6.02, +0.30) -- Morgan Stanley and UBS upgrade

        • +5.0% ROP.SW (Roche Holding CHF361.40, +17.20) -- Medilink presents, publishes data from TAISHAN-302 trial of Tam-Peli

        • +4.6% GSK.LN (GSK Plc £18.53, +0.82) -- Jideytro and Ris-Rez trial data

        • +3.9% AXFO.SS (Axfood SEK246.10, +9.20) -- Handelsbanken upgrade

        • +3.4% NAE.FP (Esso €106.00, +3.50)

        • +3.3% AZN.LN (AstraZeneca £120.98, +3.90) -- trial update

        • +3.1% HACK.SS (Hacksaw SEK93.15, +2.80) -- extends its partnership with bet365 to Spain

        • +2.9% AMBU.B.DC (Ambu DKK67.30, +1.90) -- acquires Tims Medical for $45M upfront payment and additional milestone payments of up to $20M

        • +2.8% TELIA.SS (Telia Co. SEK46.77, +1.29) -- Handelsbanken upgrade

        • +2.6% SAN.FP (Sanofi €75.14, +1.88) -- and Cheplapharm to create new strategic partnership in mature medicines

        • +2.1% ERF.FP (Eurofins Scientific €72.34, +1.46) -- obtains ISO/IEC 17065 accreditation from A2LA

      • Notable Decliners

        • -21.0% KEOC.SS (Keo Capital AB SEK7.03, -1.87) -- chairman Paolo Fidanza stands down for personal reasons, effective immediately

        • -17.9% DATA.LN (GlobalData £0.59, -0.13) -- H1 earnings

        • -12.6% SOI.FP (SOITEC €123.05, -17.75) -- sector move

        • -12.0% AIXA.GR (Aixtron €33.04, -4.50) -- sector move

        • -11.9% CER.LN (Cerillion £7.80, -1.05) -- trading update

        • -10.6% AMS.SW (ams-OSRAM CHF16.32, -1.93) -- sector move

        • -10.1% NOKIA.FH (Nokia €8.59, -0.97)

        • -8.9% HOT.GR (Hochtief €379.00, -37.20) -- contract

        • -8.3% ASM.NA (ASM International €761.60, -68.60) -- sector move

        • -8.0% ENR.GR (Siemens Energy €132.24, -11.60)

        • -7.9% SZG.GR (Salzgitter €50.70, -4.40)

        • -7.9% IFX.GR (Infineon Technologies €53.95, -4.61) -- sector move

        • -7.0% BESI.NA (BE Semiconductor Industries €175.05, -13.30) -- sector move

        • -6.8% STMPA.FP (STMicroelectronics €41.64, -3.04) -- sector move

        • -6.7% ALBLD.FP (Bilendi €9.95, -0.71)

        • -6.1% ASML.NA (ASML Holding €1,386.20, -90.60) -- sector move

        • -5.6% ANTO.LN (Antofagasta £35.79, -2.11) -- Berenberg upgrade

        • -5.4% OXIG.LN (Oxford Instruments £26.10, -1.50)

        • -4.7% MTRS.SS (Munters Group SEK140.35, -6.95) -- management changes

        • -4.5% RSW.LN (Renishaw £49.14, -2.30)

        • -4.3% IMMU.SS (Mendus SEK6.87, -0.31) -- loan facility update

        • -3.8% FRES.LN (Fresnillo £28.98, -1.16) -- CFO Mario Arreguín to retire; appoints Rodrigo Sandoval as new CFO Designate

        • -3.6% NDX1.GR (Nordex €37.88, -1.42) -- order

        • -2.7% MT.NA (ArcelorMittal €62.42, -1.72) -- statement regarding missile strike on Ukraine plant

        • -2.4% CAML.LN (Central Asia Metals £1.65, -0.04) -- M&A update

        • -1.8% ORX.SS (Orexo SEK13.04, -0.24) -- FDA acceptance of Investigational New Drug (IND) Application for OX640 for the Treatment of Anaphylaxis

    • EU companies reporting tomorrow:

      • Earnings:

        • France: Aelis Farma (AELIS.FP)

        • Southern Europe: GEK Terna (GEKTERNA.GA)

        • UK: Kier Group (KIE.LN), Trustpilot Group (TRST.LN), Princes Group (PRN.LN), IP Group (IPO.LN), McBride (MCB.LN), Everplay (EVPL.LN), LSL Property Services (LSL.LN), Sylvania Platinum (SLP.LN), Fintel (FNTL.LN), MJ Gleeson (GLE.LN), Eagle Eye Solutions Group (EYE.LN), Personal Group Holdings (PGH.LN), Springfield Properties (SPR.LN), EKF Diagnostics Holdings (EKF.LN), Mpac Group (MPAC.LN), accesso Technology Group (ACSO.LN), Alumasc Group (ALU.LN), hVIVO (HVO.LN)

      • Trading Update:

        • Nordics: Borregaard (BRG.NO)

      • Traffic: Aeroport de Paris (ADP.FP), Flughafen Wien (FLU.AV)

      • CMD/Events: Axa (CS.FP), DOF Group (DOFG.NO), Revenio Group (REG1V.FH), Studsvik (SVIK.SS), Sensorion (ALSEN.FP) 1:50 reverse stock split

  • Data:

    • Economics:

      • Switzerland Aug PPI (0.7%) y/y vs consensus (1.3%), prior (2.1%)

      • Aug CPI

        • Sweden +0.3% y/y vs preliminary +0.3%

        • Finland +2.2% y/y vs consensus +2.0%, prior +2.1%

    • Markets:

      • WTI Crude (Oct 26): +$3.31 or +3.31% to $103.36

      • €-$ (0.0052) or (0.45%) to 1.1548

      • £-$ (0.0037) or (0.27%) to 1.3484

      • €-£ (0.0013) to 0.8564

      • S&P 500 (0.48%)

      • Performance year-to-date

        • FTSE 100: +7.71%

        • DAX: +3.88%

        • CAC: (0.39%)

        • MIB: +14.87%

        • Stoxx 600: +7.40%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.